Identifying Glaucoma-Promoting Genes Using Zebrafish
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2007 - March 31, 2009
Grant ID
G2007046
Acknowledgement
Goals
The main goal of this study is to identify genes that cause ganglion cell degeneration when intraocular pressure (IOP) is elevated, a key feature of many forms of glaucoma. Using zebrafish that show elevated IOP without associated ganglion cell degeneration, we will screen for ‘interacting’ mutations that lead to injury response pathways in retinal ganglion cells and eventually cause blinding degeneration.
Summary
Glaucoma is a leading cause of blindness worldwide and yet our understanding of the genetic basis of this neurodegenerative disease remains largely unknown. One reason for this is that glaucoma is really a collection of diseases and each form is thought to be caused by mutations in multiple genes. Zebrafish are ideal for these studies because they share similar ocular anatomy, physiology and genetics as humans. In addition, zebrafish can be raised in very large numbers at modest cost, facilitating complex forward genetic endeavors. Once the key genes for glaucoma are identified, genetic tests can be developed and ultimately, research for targeted therapies can begin.
Related Grants
National Glaucoma Research
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Duke University School of Medicine
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Duke University School of Medicine
National Glaucoma Research
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California
National Glaucoma Research
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute